The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long‐term outcome in locally advanced rectal cancer
Colorectal Disease · 2023
DOI: 10.1111/codi.16667 ↗At a glance
Journal article in Colorectal Disease, 2023. Written by Ross K McMahon and 8 co-authors. Institution: Academic Unit of Surgery, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. Major MEDLINE topics: Rectal Neoplasms, Neoplasms, Second Primary. Cited 3 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cancer Research UK, Chief Scientist Office.
Abstract (original language)
Aim
Neoadjuvant rectal (NAR) score is an early surrogate for longer‐term outcomes in rectal cancer undergoing radiotherapy and resection. In an era of increasing organ preservation, resection specimens are not always available to calculate the NAR score. Post‐treatment magnetic resonance imaging (MRI) re‐staging of regression is subjective, limiting reproducibility. We explored the potential for a novel MRI‐based NAR score (mrNAR) adapted from the NAR formula.
Methods
Locally advanced rectal cancer patients undergoing neoadjuvant therapy (nCRT) and surgery were retrospectively identified between 2008 and 2020 in a single cancer network. mrNAR was calculated by adapting the NAR formula, replacing pathological (p) stages with post‐nCRT MR stages ( ymr ). Cox regression assessed relationships between clinicopathological characteristics, NAR and mrNAR with overall survival (OS) and recurrence‐free survival (RFS).
Results
In total, 381 NAR and 177 mrNAR scores were calculated. On univariate analysis NAR related to OS (hazard ratio [HR] 2.05, 95% confidence interval [CI] 1.33–3.14, p = 0.001) and RFS (HR 2.52, 95% CI 1.77–3.59, p = 0.001). NAR 3‐year OS 16 was 80%. mrNAR related to OS (HR 2.96, 95% CI 1.38–6.34, p = 0.005) and RFS (HR 2.99, 95% CI 1.49–6.00, p = 0.002). 3‐year OS for mrNAR 16 was 78%. On multivariate analysis, mrNAR was a stage‐independent predictor of OS and RFS. mrNAR corresponded to NAR score category in only 15% (positive predictive value 0.23) and 47.5% (positive predictive value 0.48) of cases for categories 16, respectively.
Conclusions
Neoadjuvant rectal score is validated as a surrogate end‐point for long‐term outcomes. mrNAR categories do not correlate with NAR but have stage‐independent prognostic value. mrNAR may represent a novel surrogate end‐point for future neoadjuvant treatments that focus on organ preservation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Academic Unit of Surgery, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- Radiology/Imaging Department, Glasgow Royal Infirmary, Glasgow, UK.
- Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
- Academic Unit of Surgery, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
ORCID profiles: Ross K McMahon
Funding
- Cancer Research UK
- Chief Scientist Office
Cite
APA
McMahon, R. K., O'Cathail, S. M., Nair, H., Steele, C. W., Platt, J. J., Digby, M., McDonald, A. C., Horgan, P. G., & Roxburgh, C. S. D. (2023). The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long‐term outcome in locally advanced rectal cancer. Colorectal Disease. https://doi.org/10.1111/codi.16667
Vancouver
McMahon RK, O'Cathail SM, Nair H, Steele CW, Platt JJ, Digby M, et al. The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long‐term outcome in locally advanced rectal cancer. Colorectal Disease. 2023. doi:10.1111/codi.16667
BibTeX
@article{McMahon2023,
author = {McMahon, Ross K and O'Cathail, Sean M and Nair, Harikrishnan and Steele, Colin W and Platt, Jonathan J and Digby, Michael and McDonald, Alec C and Horgan, Paul G and Roxburgh, Campbell S D},
title = {The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long‐term outcome in locally advanced rectal cancer},
journal = {Colorectal Disease},
year = {2023},
doi = {10.1111/codi.16667}
}
EUVIMED